Rahimy, E., Baker, K., Thompson, D., Saroj, N., & VIVID and VISTA Study Investigators. (2020). Impact of Systemic Dipeptidyl Peptidase-4 Inhibitor Use in Diabetic Macular Edema. Ophthalmic surgery, lasers & imaging retina, 51(4), 226. https://doi.org/10.3928/23258160-20200326-04
Style de citation ChicagoRahimy, Ehsan, Keith Baker, Desmond Thompson, Namrata Saroj, et VIVID and VISTA Study Investigators. "Impact of Systemic Dipeptidyl Peptidase-4 Inhibitor Use in Diabetic Macular Edema." Ophthalmic Surgery, Lasers & Imaging Retina 51, no. 4 (2020): 226. https://dx.doi.org/10.3928/23258160-20200326-04.
Style de citation MLARahimy, Ehsan, et al. "Impact of Systemic Dipeptidyl Peptidase-4 Inhibitor Use in Diabetic Macular Edema." Ophthalmic Surgery, Lasers & Imaging Retina, vol. 51, no. 4, 2020, p. 226.